Temporal echocardiographic assessment of pulmonary hypertension in idiopathic pulmonary fibrosis patients treated with nintedanib with or without oxygen therapy

BACKGROUND: Nintedanib is an inhibitor of receptor tyrosine kinases, including vascular endothelial growth factor receptor, but its effects on pulmonary hypertension (PH) in idiopathic pulmonary fibrosis (IPF) patients with chronic hypoxia were unclear. METHODS: This study included a nintedanib pros...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Pulm Med
Autors principals: Tahara, Masahiro, Oda, Keishi, Yamasaki, Kei, Kawaguchi, Takako, Sennari, Konomi, Noguchi, Shingo, Sakamoto, Noriho, Kawanami, Toshinori, Mukae, Hiroshi, Yatera, Kazuhiro
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6704493/
https://ncbi.nlm.nih.gov/pubmed/31438928
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12890-019-0918-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars